Publication | Open Access
Specific inhibitors of tyrosine-specific protein kinase. I. Synthesis and inhibitory activities of .ALPHA.-cyanocinnamamides.
22
Citations
0
References
1988
Year
Molecular PharmacologyMedicinal ChemistrySpecific InhibitorsDiversity Oriented SynthesisBiochemistryMedicineNatural SciencesTyrosine-specific Protein KinaseMechanism Of ActionPeptide ScienceAnti-cancer AgentPharmacologyPharmaceutical ChemistryInhibitory ActivitySmall MoleculesDrug Discoveryα-Cyanocinnamamide DerivativesInhibitory Activities
A series of α-cyanocinnamamide derivatives was synthesized and evaluated for inhibitory activity against tyrosine-specific protein kinase using intact plasma membrane fractions from an epidermoid carcinoma cell line, A-431 cells. Among these compounds, several novel α-cyano-4-hydroxy-3, 5-disubstituted cinnamamide derivatives, e.g., α-cyano-3-ethoxy-4-gtdrixt-5-phenyl-thiomethylcinnamamide (ST 638), showed potent inhibitory activity. The studies on the structure-activity relationship revealed that the presence of the hydroxy group at the 4 position and the double bond in the α-cyano-4-hydroxycinnamamide skeleton was important for potent inhibitory activity, and that the presence of hydrophobic groups at the 3 and 5 positions on the benzene ring also enhanced the inhibitory activity of α-cyano-4-hydroxycinnamamide derivatives.